Research Output per year
Personal profile
Personal Statement
I hold a BSc in Engineering, in Medical and Pharmaceutical Biotechnology from IMC University of Applied Science Krems Austria. My BSc was followed by an MSc in Biomedical Engineering from the University of Strathclyde, which guided me to persue my PhD in Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS).
Research Interests
My research interest is to improve the Health-care systems, through the implementation of digital tools.
My Ph.D. is involved in the development, evaluation, and implementation of a risk predictive tool for Clostridium difficile, which aims to support antibiotic prescribers to identify high-risk patients to contract the Clostridium difficile infection (CDI).
Education/Academic qualification
Master in Science, University of Strathclyde
19 Sep 2016 → 29 Sep 2017
Bachelor of Science in Engineering, IMC University of Applied Sciences Krems
15 Sep 2013 → 16 Sep 2016
Keywords
- Implementation science
- risk predictive
- Infection
- antibiotics
Fingerprint Dive into the research topics where Ansu Joseph Arumanatharayil is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Clostridium difficile
Medicine & Life Sciences
Anti-Bacterial Agents
Medicine & Life Sciences
Primary Health Care
Medicine & Life Sciences
Anaerobic Bacteria
Medicine & Life Sciences
Colitis
Medicine & Life Sciences
Spores
Medicine & Life Sciences
Infection
Medicine & Life Sciences
Prescriptions
Medicine & Life Sciences
Research Output 2018 2018
- 2 Poster
Designing a risk predictive tool for Clostridium difficile
Joseph, A. A., 4 Dec 2018. 1 p.Research output: Contribution to conference › Poster
Open Access
File
Clostridium difficile
Anti-Bacterial Agents
Anaerobic Bacteria
Colitis
Spores
Implementation of a risk predictive tool for Clostridium difficile in primary care
Joseph, A. A., 21 May 2018. 1 p.Research output: Contribution to conference › Poster
Open Access
File
Clostridium difficile
Primary Health Care
Anti-Bacterial Agents
Anaerobic Bacteria
Colitis
Activities 2017 2019
Development of a risk predictive tool for Clostridium difficile: Update
Ansu Joseph Arumanatharayil (Speaker)19 Feb 2019
Activity: Talk or presentation types › Oral presentation
Designing a risk predictive tool for Clostridium difficile
Ansu Joseph Arumanatharayil (Speaker)4 Dec 2018
Activity: Talk or presentation types › Oral presentation